Łażewska Dorota, Olejarz-Maciej Agnieszka, Kaleta Maria, Bajda Marek, Siwek Agata, Karcz Tadeusz, Doroz-Płonka Agata, Cichoń Urszula, Kuder Kamil, Kieć-Kononowicz Katarzyna
Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna Str. 9, 30-688 Kraków, Poland.
Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna Str. 9, 30-688 Kraków, Poland.
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3596-3600. doi: 10.1016/j.bmcl.2018.10.048. Epub 2018 Oct 31.
The synthesis and biological activity of 4-tert-pentylphenoxypropyl derivatives are described in this manuscript. All compounds (except one) showed human histamine H receptor affinity with K values below 760 nM. The inhibitory activity toward human monoamine oxidase B (hMAO B) was evaluated using a fluorometric Amplex-Red assay, and most of the compounds were effective in the submicromolar range. Among them, 1-(3-(4-tert-pPentylphenoxy)propyl)pyrrolidine (5) exhibited hMAO B inhibitory activity with an IC value of 4.5 nM. In addition, hMAO B inhibition by 5 was shown to be non-competitive and reversible. Further, recently described potent histamine H receptor ligands - 4-tert-pentylphenoxyalkyl derivatives (with a 4-8 carbon spacer) - were evaluated for hMAO B inhibitory activity, and some of them displayed activity in the submicromolar range. Selected compounds were also tested for human MAO A (hMAO A) inhibitory potencies and exhibited no activity. Moreover, molecular modeling studies were carried out for tested compounds to explain their molecular mechanism of hMAO B inhibition and the selectivity of compounds for hMAO B over hMAO A.
本手稿描述了4-叔戊基苯氧基丙基衍生物的合成及其生物活性。所有化合物(除一种外)均显示出对人组胺H受体的亲和力,其K值低于760 nM。使用荧光Amplex-Red测定法评估了对人单胺氧化酶B(hMAO B)的抑制活性,大多数化合物在亚微摩尔范围内有效。其中,1-(3-(4-叔戊基苯氧基)丙基)吡咯烷(5)表现出hMAO B抑制活性,IC值为4.5 nM。此外,5对hMAO B的抑制作用显示为非竞争性且可逆的。此外,对最近描述的强效组胺H受体配体——4-叔戊基苯氧基烷基衍生物(具有4-8个碳的间隔基)进行了hMAO B抑制活性评估,其中一些在亚微摩尔范围内表现出活性。还对选定的化合物进行了人MAO A(hMAO A)抑制效力测试,结果显示无活性。此外,对测试化合物进行了分子建模研究,以解释其hMAO B抑制的分子机制以及化合物对hMAO B相对于hMAO A的选择性。